Safety summary
Hazards: Choleretic; neurotoxicity; mucous membrane irritation (low risk)
Contraindications: Cardiac fibrillation, G6PD deficiency. Do not apply to or near the face of infants or children.
Maximum dermal level: 5.4%

Safety advice
A dermal maximum of 5.4% is recommended based on 8.0% menthofuran and 3.0% pulegone content, with limits of 0.5% for methofuran and 1.2% for pulegone. Peppermint oil should be avoided altogether in cases of cardiac fibrillation, and by people with a G6PD deficiency. This is a fairly common inherited enzyme deficiency, particulary in people of Chinese, West African, Mediterranean or Middle Eastern origin. People with G6PD deficiency will typically hace abnormal blood reactions to at least one of the following drugs, or will have been advised to avoid them: antimalarials; sulfonamides (antimicrobial); chloramphenicol (antibiotic); streptomycin (antibiotic); aspirin.

Tisserand, R., & Young, R. (2014). Essential Oil Safety: Second edition

General 
Some essential oils may cause photosensitivity to the skin-Use diluted in Jojoba or other complete carrier oil.

Do not ingest essential oils.

Do not apply to eyes, sensitive areas or mucous membranes.

The information on this website is not intended to be used in the diagnosis, treatment or mitigation of any physical or mental illness. Ahimsa Oils offer no advice or recommendations only general information. No therapeutic claims are made within.

Pregnant women, nursing mothers and children should not use essential oils without first consulting an appropriately trained healthcare practitioner.

The statements on this website have not been evaluated by the TGA. David Bosley however worked for a long period however in consultation with the TGA to ensure correct labelling with reference to the Ahimsa Oil product range.